EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT
C Antin1, A Tauziède-Espariat2, M-A Debily3,4
1Department of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France.
Acta Neuropathologica Communications
|November 6, 2020
Abstract
No abstract available in PubMed .


